High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma ; volume:22 ; number:1 ; day:5 ; month:10 ; year:2022 ; pages:1-10 ; date:12.2022
BMC cancer ; 22, Heft 1 (5.10.2022), 1-10, 12.2022
- Creator
-
Zhu, Yufei
Zheng, Dijie
Lei, Linhan
Cai, Kun
Xie, Huahua
Zheng, Jian
Yu, Chao
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-10128-y
- URN
-
urn:nbn:de:101:1-2022122221014608834659
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhu, Yufei
- Zheng, Dijie
- Lei, Linhan
- Cai, Kun
- Xie, Huahua
- Zheng, Jian
- Yu, Chao
- SpringerLink (Online service)
Other Objects (12)
Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Impact of syndecan, heparanase and KAI-1 on the prognosis and survival of pancreatic ductal adenocarcinoma after surgery
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma
Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Impact of syndecan, heparanase and KAI-1 on the prognosis and survival of pancreatic ductal adenocarcinoma after surgery
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma
Overexpression of CDCA8 predicts poor prognosis and drug insensitivity in lung adenocarcinoma
Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma
Clinicopathological features and prognosis analysis of proximal colonic mucinous adenocarcinoma
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Impact of syndecan, heparanase and KAI-1 on the prognosis and survival of pancreatic ductal adenocarcinoma after surgery
Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma
Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma
Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma